Robert H. Rubin

17.9k total citations · 2 hit papers
136 papers, 9.4k citations indexed

About

Robert H. Rubin is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Robert H. Rubin has authored 136 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Epidemiology, 25 papers in Oncology and 22 papers in Surgery. Recurrent topics in Robert H. Rubin's work include Cytomegalovirus and herpesvirus research (41 papers), Renal Transplantation Outcomes and Treatments (21 papers) and Polyomavirus and related diseases (15 papers). Robert H. Rubin is often cited by papers focused on Cytomegalovirus and herpesvirus research (41 papers), Renal Transplantation Outcomes and Treatments (21 papers) and Polyomavirus and related diseases (15 papers). Robert H. Rubin collaborates with scholars based in United States, United Kingdom and Netherlands. Robert H. Rubin's co-authors include Jay A. Fishman, Nina Tolkoff-Rubin, A. Benedict Cosimi, Paul S. Russell, John T. Herrin, Lowell S. Young, Alan J. Fischman, Francis L. Delmonico, Martin Hirsch and Amy A. Pruitt and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Robert H. Rubin

135 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infection in Organ-Transplant Recipients

1998 1.1k citations Jay A. Fishman, Robert H. Rubin New England Journal of Medicine profile →
Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts

1981 385 citations Robert B. Colvin, Robert H. Rubin et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert H. Rubin United States	48	5.5k	1.8k	1.7k	1.4k	1.4k	136	9.4k
Mark D. Pescovitz United States	54	4.0k 0.7×	3.4k 1.9×	1.2k 0.7×	1.8k 1.2×	3.6k 2.5×	190	11.5k
Nina Tolkoff-Rubin United States	49	3.0k 0.5×	3.2k 1.8×	608 0.4×	971 0.7×	4.8k 3.4×	142	9.9k
Juan Berenguer Spain	58	7.0k 1.3×	2.5k 1.4×	3.4k 2.1×	1.2k 0.9×	521 0.4×	467	13.7k
M. Ho Hong Kong	44	2.7k 0.5×	1.0k 0.6×	1.5k 0.9×	2.4k 1.7×	330 0.2×	171	7.3k
Robin K. Avery United States	53	6.0k 1.1×	1.8k 1.0×	4.7k 2.8×	1.8k 1.3×	1.2k 0.9×	226	10.6k
Francisco M. Marty United States	52	4.8k 0.9×	784 0.4×	3.5k 2.1×	1.5k 1.0×	758 0.5×	204	8.2k
Thomas Fehr Switzerland	40	1.4k 0.3×	921 0.5×	697 0.4×	788 0.6×	999 0.7×	148	6.3k
Henry H. Balfour United States	60	7.4k 1.3×	722 0.4×	6.0k 3.6×	3.5k 2.4×	417 0.3×	229	15.2k
Atul Humar Canada	67	10.6k 1.9×	2.2k 1.2×	4.1k 2.5×	2.9k 2.1×	1.6k 1.1×	275	14.4k
José María Aguado Spain	48	4.4k 0.8×	1.9k 1.0×	3.5k 2.1×	831 0.6×	764 0.5×	298	7.9k

Countries citing papers authored by Robert H. Rubin

Since Specialization

Citations

This map shows the geographic impact of Robert H. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Rubin more than expected).

Fields of papers citing papers by Robert H. Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Rubin. The network helps show where Robert H. Rubin may publish in the future.

Co-authorship network of co-authors of Robert H. Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Rubin. A scholar is included among the top collaborators of Robert H. Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Rubin. Robert H. Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gill, Ritu R., Rachel E. Factor, Julie M. Bryar, et al.. (2009). Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies. Academic Radiology. 16(11). 1408–1415. 15 indexed citations

Rubin, Robert H., Matthew D. Gilman, & Richard L. Kradin. (2006). Case 1-2006. New England Journal of Medicine. 354(2). 180–187. 2 indexed citations

Pereyra, Florencia & Robert H. Rubin. (2004). Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Current Opinion in Infectious Diseases. 17(4). 357–361. 79 indexed citations

Rubin, Robert H., Mary Etta King, & Eugene J. Mark. (2003). Case 7-2003. New England Journal of Medicine. 348(9). 834–843. 8 indexed citations

Dropulic, Lesia, Robert H. Rubin, & John G. Bartlett. (2003). Smallpox Vaccination and the Patient with an Organ Transplant. Clinical Infectious Diseases. 36(6). 786–788. 10 indexed citations

Fischman, Alan J., Nathaniel M. Alpert, & Robert H. Rubin. (2002). Pharmacokinetic Imaging. Clinical Pharmacokinetics. 41(8). 581–602. 73 indexed citations

Mylonakis, Eleftherios, et al.. (2001). BK VIRUS IN SOLID ORGAN TRANSPLANT RECIPIENTS: AN EMERGING SYNDROME. Transplantation. 72(10). 1587–1592. 131 indexed citations

Turgeon, Nathalie, Jay A. Fishman, Nesli Basgoz, et al.. (1998). EFFECT OF ORAL ACYCLOVIR OR GANCICLOVIR THERAPY AFTER PREEMPTIVE INTRAVENOUS GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS SEROPOSITIVE RENAL AND LIVER TRANSPLANT RECIPIENTS RECEIVING ANTILYMPHOCYTE ANTIBODY THERAPY1. Transplantation. 66(12). 1780–1786. 38 indexed citations

Rubin, Robert H.. (1997). CYTOMEGALOVIRUS INFECTION IN THE LIVER TRANSPLANT RECIPIENT. Clinics in Liver Disease. 1(2). 439–452. 9 indexed citations

10.

Fischman, Alan J., John W. Babich, Nathaniel M. Alpert, et al.. (1997). Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography. Clinical Microbiology and Infection. 3(1). 63–72. 15 indexed citations

11.

Babich, John W., Robert H. Rubin, Wendy Graham, et al.. (1996). 18F-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219). Nuclear Medicine and Biology. 23(8). 995–998. 25 indexed citations

12.

Rubin, Robert H. & Alan J. Fischman. (1994). The use of radiolabeled, nonspecific immunoglobulin in the detection of focal inflammation. Seminars in Nuclear Medicine. 24(2). 169–179. 32 indexed citations

13.

Fischman, Alan J., John W. Babich, & Robert H. Rubin. (1994). Infection imaging with technetium-99m-labeled chemotactic peptide analogs. Seminars in Nuclear Medicine. 24(2). 154–168. 37 indexed citations

14.

Hibberd, Patricia L. & Robert H. Rubin. (1994). Clinical Aspects of Fungal Infection in Organ Transplant Recipients. Clinical Infectious Diseases. 19(Supplement_1). S33–S40. 102 indexed citations

15.

Babich, John W., Wendy Graham, Stephen C. Dragotakes, et al.. (1993). Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit.. PubMed. 34(12). 2176–81. 56 indexed citations

16.

Tolkoff-Rubin, Nina & Robert H. Rubin. (1988). Ciprofloxacin in management of urinary tract infection. Urology. 31(4). 359–367. 9 indexed citations

17.

Shoham, Shlomo, et al.. (1987). Family Parameters of Violent Prisoners. The Journal of Social Psychology. 127(1). 83–91. 9 indexed citations

18.

Doody, Daniel P., et al.. (1986). Changes in the phenotype of T-cell subset determinants following murine cytomegalovirus infection. Clinical Immunology and Immunopathology. 40(3). 466–475. 11 indexed citations

19.

Rubin, Robert H., Nina Tolkoff-Rubin, Donald Oliver, et al.. (1985). MULTICENTER SEROEPIDEMIOLOGIC STUDY OF THE IMPACT OF CYTOMEGALOVIRUS INFECTION ON RENAL TRANSPLANTATION. Transplantation. 40(3). 243–248. 141 indexed citations

20.

Avner, Ellis D., et al.. (1983). Single-dose amoxicillin therapy of uncomplicated pediatric urinary tract infections. The Journal of Pediatrics. 102(4). 623–627. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact